P. Bakhtiani

Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels

W. Kenneth Ward, Ahmad Haidar, Jessica R. Castle, 2014, Diabetes Care.

Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System

W. Ward, J. Castle, J. El Youssef, 2015, Diabetes Care.

Mechanisms of glucagon degradation at alkaline pH

W. Ward, C. Roberts, L. David, 2013, Peptides.

A Novel, Stable, Aqueous Glucagon Formulation Using Ferulic Acid as an Excipient

W. Ward, C. Roberts, L. David, 2014, Journal of diabetes science and technology.

Biochemical stabilization of glucagon at alkaline pH.

W. Ward, C. Roberts, L. David, 2014, Diabetes technology & therapeutics.

A review of artificial pancreas technologies with an emphasis on bi‐hormonal therapy

W. Ward, J. Castle, J. Youssef, 2013, Diabetes, obesity & metabolism.

Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.

M R Lasarev, W. Ward, J. Castle, 2015, Journal of diabetes and its complications.

Impact of hyperbaric oxygen on diabetic ulcers is unaffected by glycemic control.

P. Bakhtiani, O. Mansuri, M. Jakoby, 2015, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

Automated Control of an Adaptive Bihormonal, Dual-Sensor Artificial Pancreas and Evaluation During Inpatient Studies

W. Kenneth Ward, David Bauer, Nicholas Preiser, 2014, IEEE Transactions on Biomedical Engineering.